Active substance linagliptin International non-proprietary name (INN) or common name linagliptin Therapeutic area (MeSH) Diabetes Mellitus, Type 2 Anatomical therapeutic chemical (ATC) code Linagliptin is an Antidiabetic Agent belonging to the pharmacological class of Dipeptyl peptidase-4 (DPP-4) inhibitors. Linagliptin is approved for treating type 2 diabetes mellitus. It is used to improve glycemic control by blocking the enzyme DPP-4. It helps to increase levels of incretin hormones ... Includes Linagliptin indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse ... Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
